demand for minimally invasive and non-invasive treatment drives the neuromodulation market

Neuromodulation Market

January 2013

http://bit.ly/neuromodulation-2017

http://www.researchonglobalmarkets.com/


Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non-invasive treatment. With advancements in technology, neuromodulation is expected to become a promising therapeutic area and high growth industry in the next decade, as it offers symptomatic relief mainly from chronic pain, incontinence, heart failure, headache, depression, epilepsy, etc.

The neuromodulation devices market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS).

MARKET INSIGHTS

www.researchonglobalmarkets.com




https://www.facebook.com/pages/Research-on-Global-Markets/536186973101152


http://www.linkedin.com/groups?gid=5131467&mostPopular=&trk=tyah


https://twitter.com/researchonglobe




The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is altered due to biological responses produced by electrical stimulation or drug infusion. These devices include small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation.

Neuromodulation can have applications in any area of the body and can treat several diseases like chronic pain, epilepsy, psychiatric disorder, movement disorder, cardiovascular disorder, genitourinary and colorectal disorder, stroke and brain injury, and gastric disorder.

KNOW YOUR MARKET BETTER














MARKET DRIVERS AND CHALLENGES

The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimers, epilepsy, spinal cord injury, and Parkinsons disease. According to the International Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million people currently (2012) suffer from Parkinson disease in the U.S.

The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor offers the neuromodulation industry opportunities to grow in the next five years. The market for treatment of tinnitus, in particular, represents an emerging application of neuromodulation. According to the American Tinnitus Association, about 50 million people currently (2012) suffer from this disease in the U.S.












Internal Neurostimulation

Spinal Cord Stimulation (SCS)

Failed Back Surgery Syndrome

Chronic Pain

Ischemic Pain

Deep Brain Stimulation (DBS)

Movement Disorders

Parkinsons Disease

Alzheimers Disease

Dystonia

MARKET SEGMENTATION - BY PROCEDURE













Tourettes Syndrome

Chronic Pain

Depression

Post-Traumatic Coma

Sacral Nerve Stimulation (SNS)

Urine Incontinence

Fecal Incontinence

Vagus Nerve Stimulation (VNS)

Epilepsy disease

Heart Failure



Continued..












Tinnitus

Gastric Electrical Stimulation (GES)

Gastroparesis

External Neurostimulation

Transcranial Magnetic Stimulation (TMS)

Depression

Tinnitus

Migraine

Stroke

Transcutaneous Electrical Nerve Stimulation (TENS)



Continued..












Market segmentation for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and others.

Market estimation for different neuromodulation techniques as well as geographic analysis of each segment in North America, Europe, Asia-Pacific, and Rest of the World.

REPORT COVERAGE


FAST FACTS

As technologies develop and the number of trained physician increases, the likelihood of neuromodulation being seen as life-changing treatment will increase dramatically. It is estimated that the market for neuromodulation will be shared largely by deep brain stimulation and spinal cord stimulation.












Medtronic, Inc. (U.S.)

Cyberonics, Inc. (U.S.)

Boston Scientific Corporation (U.S.)

St. Jude Medical (U.S.)

Enteromedics, Inc (U.S.)

Neuropace, Inc (U.S.)

Zynex, Inc (U.S.)

Neuronetics, Inc (U.S.)

KEY PLAYERS IN THE MARKET













North America

Europe

Asia-Pacific

Rest of the World

KEY REGIONS COVERED IN THE STUDY


Want to know more?You are just a click away!













Introduction

Executive summary

Market overview

Global neuromodulation market (internal & external)

Geographic analysis

Competitive landscape

Company profiles

TABLE OF CONTENTS













REPORT DETAILS


Publish date: Jan 16, 2013

Number of slides: 193

Geographic coverage: Global

Available format: PDF, CD, Hardcopy

Price for Single User License: USD 4,650

Price for Site License: USD 7,150

Price for Global User License: USD 9,000

Delivery Time: Within 1 business day

Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal












Research on Global Markets is a leading source for market research on various sectors globally,

offering premium research content from worldwide publishers of market research reports. Our

database hosts premium market research content developed by global publishers

It offers premium industry research reports, company profiles and country briefs.

For further information, get in touch with us:E-mail : [email protected]

Call : US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600

ABOUT US

To view more details regarding this premium market research report,

please click here












demand for minimally invasive and non-invasive treatment drives the neuromodulation market

Documents